Hyperbaric Oxygen Therapy (HBOT) (CPB 0172, reviewed 2026-04-21)
Summary
Aetna considers systemic hyperbaric oxygen therapy (HBOT) medically necessary for conditions including acute air or gas embolism, acute carbon monoxide poisoning, acute thermal burns, decompression sickness, gas gangrene, and chronic refractory stage 3 or 4 osteomyelitis, with usual numbers of sessions listed for each. Continued HBOT for wounds is not considered medically necessary if measurable signs of healing have not been demonstrated within any 30-day period of treatment. Aetna considers systemic HBOT experimental, investigational, or unproven for conditions including Alzheimer's disease, autism spectrum disorders, traumatic brain injury, and COVID-19, and considers topical HBOT and vaporous hyperoxia therapy for non-healing diabetic foot wounds experimental, investigational, or unproven.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.